GTC
KRRO icon

Ghost Tree Capital’s Korro Bio KRRO Stock Holding History

Ghost Tree Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,000
Closed -$950K – 62
2021
Q1 		$950K Buy
+2,000
New +$3.89M 0.22% 50

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Ghost Tree Capital's KRRO Position: Q3 2024 in Review

Ghost Tree Capital increased its Korro Bio (KRRO) stake by 10% in Q3 2024, buying an estimated $421K and bringing the position to 110,000 shares worth $3.68M. The position accounts for 1.11% of the portfolio, ranked #32.

Ghost Tree Capital first reported a position in KRRO in Q2 2024 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2024.

  • Ghost Tree Capital held 110,000 shares of Korro Bio worth $3.68M as of Q3 2024.
  • Ghost Tree Capital bought 10,000 Korro Bio shares in Q3 2024, an estimated $421K.
  • Korro Bio made up 1.11% of Ghost Tree Capital's portfolio in Q3 2024, its #32 holding.
  • Ghost Tree Capital first reported a position in Korro Bio in Q2 2024 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.